MCAS, histamine intolerance and nitric oxide: the missing element

By Jeff Butterworth N.D — Specialist Naturopath · 30 years in clinical practice

Low-histamine diets, antihistamines, DAO enzymes, mast-cell stabilisers — if you've done all of it and still flush, itch, race and crash, here's the piece nobody mentions: your body's own mast-cell stabiliser is nitric oxide, and mast-cell disease erodes it.

If you live with mast cell activation syndrome (MCAS) or histamine intolerance, you have almost certainly become an expert on avoidance. You know the histamine food lists by heart. You know which antihistamines you take in the morning and which at night. You may have tried DAO enzymes, quercetin, cromolyn, ketotifen, low-dose naltrexone, a low-histamine diet so narrow it fits on an index card. And you are probably still managing rather than well: still flushing, still reacting to things that never used to bother you, still cold in the hands and hot in the face, still standing up too fast and feeling your heart take off.

I have worked with people like this for most of my thirty years in practice, and I want to offer you a different place to stand. Almost everything in the MCAS conversation is about stopping histamine — blocking its release, blocking its receptors, breaking it down faster, keeping it out of the diet. Almost none of it asks what your body uses to keep mast cells calm in the first place.

The answer has been in the immunology literature since the early 1990s. Your mast cells sit on the walls of your blood vessels, and the lining of those vessels bathes them continuously in a molecule that tells them to stand down. That molecule is nitric oxide. Mast-cell disease — through inflammation, oxidative stress and the histamine surges themselves — erodes your supply of it. Which means the more active your mast cells become, the less of your natural brake you have. That is the loop, and it is why avoidance alone so rarely gets people out.

This is the missing element. Let me build it carefully, because the science here has nuance, and you deserve the nuance.

Part one — what histamine intolerance and MCAS actually are

Histamine, the useful molecule

A mast cell, packed with granules of histamine and other mediators

Histamine is not the enemy. It is a signalling molecule you cannot live without: it wakes you up in the morning, drives stomach acid for digestion, modulates immunity and inflammation, and opens blood vessels so immune cells can reach an injury. Trouble starts only when there is more histamine than your body can clear — either because too much is being released, or because too little is being broken down, or both.

Histamine is broken down by two enzymes:

• DAO (diamine oxidase) works outside cells — mainly in the gut lining — and handles histamine from food and from gut bacteria. It needs copper, vitamin B6 and vitamin C as cofactors. It is easily depleted by gut inflammation, alcohol and a long list of common medications.

• HNMT (histamine N-methyltransferase) works inside cells — brain, liver, airways — and clears histamine by methylating it. It needs SAMe, the universal methyl donor, which is exactly what MTHFR variants and folate/B12 shortfalls limit. If you have read my MTHFR article, you'll see the two stories are cousins.

Histamine intolerance

Histamine intolerance (HIT) is not an allergy. It is a mismatch between histamine load and histamine clearance, most often because DAO activity is low [1, 2]. The result is that a normal meal — aged cheese, wine, cured meat, tomatoes, spinach, fermented foods, leftovers — delivers more histamine than the gut can neutralise, and it spills into the circulation.

The symptoms read like a list of unrelated complaints, which is why it takes people years to get the diagnosis: headache and migraine, flushing, nasal congestion and runny nose after eating, hives or itch, bloating and diarrhoea, palpitations, low blood pressure or dizziness, anxiety, sleep disturbance, menstrual pain. Prevalence estimates run at around 1–3% of the population, mostly middle-aged women — but DAO deficiency is under-tested and I suspect the true number is higher [2].

Mast cell activation syndrome

Degranulation: the mast cell releases its histamine into the surrounding tissue

MCAS is a different, and larger, problem. Mast cells are immune cells that live in every tissue that touches the outside world — skin, gut, airways, and, critically, packed around blood vessels and nerves. They are granaries of inflammatory chemicals: histamine, tryptase, heparin, prostaglandins, leukotrienes, cytokines. In MCAS, these cells release their contents too easily and too often, in response to triggers that should not provoke them — heat, cold, pressure, exercise, stress, foods, smells, medications, hormonal shifts [3, 4].

Because mast cells are everywhere, MCAS is everywhere: skin (flushing, hives, itching, dermatographia), gut (pain, bloating, reflux, alternating bowels), cardiovascular (palpitations, low blood pressure, fainting, the racing heart on standing that overlaps with POTS), respiratory (wheeze, throat tightness, congestion), neurological (brain fog, headache, anxiety, sensory sensitivity), and constitutional (fatigue, temperature dysregulation, "reacting to everything"). The formal diagnosis rests on typical symptoms in two or more organ systems, a measurable rise in mast-cell mediators during a flare — tryptase, N-methylhistamine or prostaglandin D2 metabolites — and response to mast-cell-directed treatment [3, 4].

Why the same condition looks so different in different people

This is the nuance the food lists skip.

• Trigger load. Histamine, like water in a bucket, only overflows past a threshold. Diet, gut bacteria that produce histamine, alcohol, medications that block DAO (some antidepressants, painkillers, antibiotics, blood-pressure drugs), and mast-cell triggers all pour into the same bucket. Two people with identical DAO activity have different symptoms because their buckets are differently full.

• Clearance capacity. DAO is genetically variable (the AOC1 gene), and HNMT depends on methylation status. A person with an MTHFR variant and low B12 clears histamine more slowly regardless of what they eat.

• Gut integrity. DAO lives in the intestinal lining. Anything that damages that lining — inflammation, dysbiosis, coeliac disease, NSAIDs — takes DAO with it.

• Hormones. Oestrogen stimulates mast cells and suppresses DAO; progesterone does the opposite. This is why symptoms track the menstrual cycle, why they can surge in perimenopause, and why pregnancy — when the placenta makes vast amounts of DAO — often brings temporary relief [2].

• The nervous system. Mast cells and nerves are wired together. Stress hormones degranulate mast cells directly. A dysregulated, sympathetic-dominant nervous system keeps the bucket permanently near the brim.

• The vascular terrain. And this is the one nobody talks about. Mast cells are perivascular. The environment they sit in — inflamed or calm, oxidatively stressed or protected, nitric-oxide-rich or nitric-oxide-poor — sets their threshold for firing. That environment is what the rest of this article is about.

Part two — the connection nobody talks about: nitric oxide and the mast cell

What nitric oxide does

The endothelium releases nitric oxide into the vessel wall, relaxing it

Nitric oxide (NO) is a gas made continuously in the lining of your blood vessels. It tells the vessel wall to relax, governs blood flow and blood pressure, keeps blood cells from sticking to the vessel wall, and — the part that matters here — acts as a local anti-inflammatory signal to the immune cells living in and around the vessel. Under normal conditions there is a steady, low, tonic level of it, produced by the endothelial enzyme eNOS. By around 40 most adults make roughly half what they did at 20, and inflammation of any kind lowers it further.

Mechanism one: nitric oxide is your body's own mast-cell stabiliser

Nitric oxide acts as the body’s own mast-cell stabiliser, keeping granules inside

In 1991, Paul Kubes and colleagues published a paper in PNAS showing that when you block nitric oxide production in living blood vessels, white cells immediately begin sticking to the vessel wall and — this is the key observation — mast cells around the vessels degranulate [5]. The endothelium's nitric oxide was actively holding them quiet. In 1996, the same group showed that nitric oxide inhibits numerous features of mast-cell-induced inflammation: the degranulation, the leakage of fluid from vessels, the recruitment of white cells [6].

The same year Kubes published, Salvemini's group showed that mast cells themselves make a nitric-oxide-like factor that modulates their own histamine release — an internal brake [7]. By 2002, Coleman could review a decade of work and conclude that nitric oxide is a physiological regulator of mast-cell activation and mast-cell-mediated inflammation, acting largely to inhibit mediator release [8].

Read that again in the context of MCAS. Your body has a built-in mast-cell stabiliser. It is made by your blood vessels, it bathes your mast cells continuously, and its job is to raise their threshold for firing. Cromolyn, ketotifen and quercetin are, in a sense, pharmacological stand-ins for what tonic nitric oxide does natively.

Mechanism two: mast-cell disease erodes nitric oxide

Now the other direction. Chronic mast-cell activation is chronic inflammation, and chronic inflammation does three things to the nitric oxide system:

1. Oxidative stress uncouples the enzyme. Mast-cell mediators — tryptase, TNF-alpha, leukotrienes — drive the production of superoxide in the vessel wall. Superoxide destroys tetrahydrobiopterin (BH4), the cofactor eNOS needs to stay coupled. Without it, the enzyme flips: instead of making nitric oxide it makes more superoxide. The tonic, protective NO supply collapses.

2. Superoxide destroys the NO that is made. Superoxide and nitric oxide react almost instantly to form peroxynitrite — toxic to the vessel wall and, in a vicious touch, itself a trigger of mast-cell degranulation.

3. Histamine hijacks the system for spikes. Histamine acting on H1 receptors on the endothelium triggers a burst of NO release — this is a large part of why a histamine surge causes flushing, headache and a drop in blood pressure [9]. But a burst is not a tone. Repeated bursts on a depleted system leave you with the worst of both worlds: too little steady NO to keep mast cells calm and vessels stable, and unstable surges when they fire. Cold hands and a hot face. Low blood pressure lying down and a racing heart standing up.

So the picture in established MCAS is not simply "too much NO" or "too little NO". It is dysregulated NO: a low, unstable baseline with inflammatory spikes. The therapeutic goal is to restore the baseline — the tonic, endothelial supply — not to add to the spikes.

Mechanism three: the POTS overlap tells the same story

POTS: the autonomic circulation is where mast-cell disease and low nitric oxide overlap

A large proportion of people with MCAS also have postural orthostatic tachycardia syndrome (POTS) — the racing heart and light-headedness on standing — and the overlap is not a coincidence [10]. Julian Stewart's laboratory showed that in POTS, nitric oxide production in the skin's blood vessels is specifically decreased [11], and that ascorbate — vitamin C — improves the abnormal circulation [12]. Vitamin C works, in that setting, by stabilising BH4 and recoupling eNOS. The vascular terrain of the MCAS/POTS patient is a nitric-oxide-deficient terrain, and it has been shown to respond to the same intervention that recouples the enzyme.

Mechanism four: the shared cofactors

One cofactor, several enzymes: nitric oxide and neurotransmitter synthesis compete for the same supply

Vitamin C, which recouples eNOS, is also a cofactor for DAO and directly degrades histamine — depleting it in volunteers raised blood histamine, and supplementing it lowered histamine and improved symptoms in people with allergic and infectious disease [13, 14]. Magnesium, which relaxes vessel walls and supports NO signalling, also restrains histamine release; magnesium deficiency in animals produces a histamine-driven inflammatory state. Copper and B6, DAO's other cofactors, are also needed by the antioxidant enzymes that protect NO. The nutrients that support your clearance system and the nutrients that support your nitric oxide system are largely the same nutrients.

The loop, stated plainly

The loop: mast-cell activation lowers nitric oxide, and low nitric oxide destabilises mast cells

Mast cells fire → inflammation and oxidative stress → eNOS uncouples → tonic NO falls → mast cells lose their natural brake → mast cells fire more easily. Avoidance lowers the trigger load and buys relief, but it does nothing to restore the brake. That is why people can be scrupulously careful and still find their threshold sinking year on year.

Part three — why restoring nitric oxide is the foundational intervention

I want to be precise about foundational. Not "also helpful". The thing that has to be in place for the rest to work.

First, because it restores the brake rather than just reducing the load. Every other intervention in the MCAS toolkit addresses histamine after the fact. Tonic nitric oxide raises the threshold before it.

Second, because it can be done without histamine-releasing inputs — through a pathway inflammation cannot touch. This is the part that makes it practical. The enzymatic pathway — eNOS, BH4, arginine — is the one inflammation uncouples. But your body has a second route: the nitrate–nitrite–NO pathway. Dietary nitrates from beetroot and rocket are concentrated in saliva, converted to nitrite by bacteria on the tongue, and then to nitric oxide in the stomach and blood. It needs no enzyme, no cofactor, and it is unaffected by the oxidative stress that cripples the first route [15]. It delivers tonic, low-level NO — not spikes.

Third, because the compromised pathway can be recoupled. Vitamin C stabilises BH4 and restores eNOS coupling in human endothelium [16], and it is precisely the intervention shown to improve circulation in POTS [12]. L-citrulline raises arginine, the enzyme's raw material, without the gut side-effects of arginine itself. Antioxidants protect the NO you make from superoxide.

Fourth, because the delivery system is the point. Every nutrient, every mast-cell stabiliser, every antihistamine has to travel through vessels to reach tissue. Constricted, NO-poor vessels deliver less of everything.

Fifth, because it is measurable. A saliva nitric oxide strip reads your status in fifteen seconds. Optimal is 220–435 mg/L, sweet spot around 350. In the MCAS population I would put it alongside a symptom diary as the most useful weekly measurement you can make.

The honest nuance

Three things need saying, because I would rather you trust me than be impressed by me.

Histamine itself releases NO. Yes — acutely, as a burst, via H1 receptors. Restoring tonic NO through the nitrate pathway is a different physiological event from a histamine-driven spike, and the mast-cell literature is consistent that the tonic supply is inhibitory to degranulation. Optimise the baseline; don't chase spikes. Test into the optimal range rather than beyond it.

Some people with MCAS react to anything new. If that is you, start Ultimate 4 at a quarter scoop for the first week and build up. It contains no spinach, no fermented ingredients, no citrus and no added flavours; the one botanical that occasionally bothers very reactive people is hibiscus, and a slow ramp identifies that in days.

Acid suppression blunts the stomach step of the nitrate pathway. Many people with MCAS take H2 blockers (famotidine), and some take proton pump inhibitors. The conversion of nitrite to nitric oxide in the stomach depends on acid, and a PPI has been shown to abolish the blood-pressure effect of oral nitrite in humans [17]. H2 blockers raise gastric pH less than PPIs, but the principle holds. Take Ultimate 4 away from the antihistamine dose, at the time of day your stomach is most acidic, and remember that the tongue step and the citrulline pathway still work regardless. The nitric oxide strip will tell you whether your pathway is open.

Part four — how to do it with Ultimate 4

I formulated Ultimate 4 as a daily nitric-oxide foundation for adults over 40. When I lay its ingredients against the histamine problem, they line up better than I could have planned — because the same cofactors run both systems.

Ultimate 4 does not contain spinach, fermented ingredients, citrus, dairy, gluten, artificial colours or flavours.

The pattern I use in practice

1. Test first. Nitric oxide strip on waking, before eating, drinking or brushing. Start a simple daily score for flushing, gut, heart rate on standing, and energy. If you don't already have them, ask your practitioner about DAO activity, serum tryptase and, if relevant, a homocysteine and B12.

2. Ramp Ultimate 4. Quarter scoop for week one, half scoop for week two, full scoop from week three — in water, away from your antihistamine dose, when the stomach is most acidic (first thing, or before the main meal).

3. Feed the pathway with low-histamine nitrate. Rocket, beetroot, bok choy, celery, lettuce and fennel are all nitrate-rich and low-histamine. Skip spinach for now. Chew well; the tongue is where the conversion starts.

4. Protect the pathway. Antibacterial mouthwash and antiseptic toothpaste kill the tongue bacteria the pathway depends on [18]. Nose-breathe — histamine congestion pushes people into mouth-breathing, which cuts the nasal NO that keeps airways and vessels calm. Hum on the out-breath for a minute each morning.

5. Keep your clearance cofactors. Vitamin C is in Ultimate 4; add copper and B6 (P5P) for DAO with your practitioner, and if you carry an MTHFR variant, read the companion article — HNMT needs your methylation to work.

6. Calm the nervous system. Mast cells fire on stress hormones. The daily walk, the breathwork and the sleep rules in the diet & lifestyle protocol are not decoration here — they are mast-cell stabilisers.

7. Retest. Strip weekly. Symptom scores weekly. Expect the strip to move first, then standing heart rate and flushing, then your tolerance of foods and environments you had given up on. Retest tryptase or DAO with your practitioner at week 12.

Full details, the daily routine and a printable tracker are in the MCAS & histamine nitric oxide protocol at butterworthhealth.com/pages/protocols.

What I tell people with MCAS and histamine intolerance now

You have spent years lowering the load. Nobody has helped you restore the brake.

Your blood vessels make a molecule whose job is to keep your mast cells calm, and the disease has been quietly stealing it — leaving you with less of it every year, more reactive every year, and more convinced that the answer is a narrower life. It isn't. The answer is to rebuild tonic nitric oxide through the pathway inflammation cannot touch, recouple the one it can, and then watch how differently the rest of your toolkit works.

That is the missing element. It has been in the immunology journals since 1991.

— Jeff

If you want to learn more about Nitric Oxide Optimisation then join my community. 

https://www.facebook.com/groups/butterworthhealthoptimisation

This article is educational and does not replace individual medical advice. Supplements support healthy function; they do not treat, cure or prevent any disease. MCAS and histamine intolerance should be diagnosed and managed with your healthcare practitioner; do not stop prescribed medication without their guidance. If you are highly reactive, introduce any new product slowly and with your practitioner's knowledge.

References

1. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–1196.

2. Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Latorre-Moratalla M, Vidal-Carou MC. Histamine intolerance: the current state of the art. Biomolecules. 2020;10(8):1181.

3. Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215–225.

4. Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017;140(2):349–355.

5. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88(11):4651–4655.

6. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation. 1996;93(2):318–326.

7. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane J. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol. 1991;17(Suppl 3):S258–S264; and Salvemini D, et al. Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Biochem Biophys Res Commun. 1991;180(2):896–902.

8. Coleman JW. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol. 2002;129(1):4–10.

9. Van de Voorde J, Leusen I. Role of the endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur J Pharmacol. 1983;87(1):113–120; and Toda N. Mechanism of histamine actions in human coronary arteries. Circ Res. 1987;61(2):280–286.

10. Shibao C, Arzubiaga C, Roberts LJ, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45(3):385–390.

11. Stewart JM, Medow MS, Minson CT, Taneja I. Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2007;293(4):H2161–H2167.

12. Stewart JM, Medow MS, Glover JL, Montgomery LD. Ascorbate improves circulation in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2011;301(3):H1033–H1042.

13. Johnston CS, Martin LJ, Cai X. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr. 1992;11(2):172–176.

14. Hagel AF, Layritz CM, Hagel WH, et al. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol. 2013;386(9):789–793.

15. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7(2):156–167.

16. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem. 2001;276(1):40–47.

17. Montenegro MF, Sundqvist ML, Larsen FJ, et al. Blood pressure-lowering effect of orally ingested nitrite is abolished by a proton pump inhibitor. Hypertension. 2017;69(1):23–31.

18. Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013;55:93–100.

19. Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51–59.